Betta Pharmaceuticals Co Ltd (300558) — Capital Reinvestment Ratio

Latest as of September 2025: 0.40x

Betta Pharmaceuticals Co Ltd (300558) has a Capital Reinvestment Ratio of 0.40x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥224.45 Million) in capital expenditures (CN¥90.43 Million). See how much free cash does Betta Pharmaceuticals Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.40x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥224.45 Million
CNY

Capital Expenditures

CN¥90.43 Million
CNY

Data as of

Sep 2025
Most recent filing

Betta Pharmaceuticals Co Ltd Capital Reinvestment Ratio (2011–2025)

This chart tracks Betta Pharmaceuticals Co Ltd's Capital Reinvestment Ratio across 15 annual periods.

Annual Capital Reinvestment Ratio for Betta Pharmaceuticals Co Ltd (2011–2025)

Year-by-year Capital Reinvestment Ratio for Betta Pharmaceuticals Co Ltd from 2011 to 2025. For live market cap and broader valuation context, see Betta Pharmaceuticals Co Ltd (300558) total market value.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.68x CN¥911.26 Million CN¥616.68 Million ▼ -25.5%
2024 0.91x CN¥911.17 Million CN¥827.59 Million ▼ -24.2%
2023 1.20x CN¥914.23 Million CN¥1.10 Billion ▼ -63.6%
2022 3.29x CN¥306.74 Million CN¥1.01 Billion ▲ +128.8%
2021 1.44x CN¥526.63 Million CN¥758.38 Million ▲ +35.6%
2020 1.06x CN¥646.02 Million CN¥685.84 Million ▼ -5.0%
2019 1.12x CN¥555.07 Million CN¥620.42 Million ▼ -47.9%
2018 2.15x CN¥286.40 Million CN¥614.83 Million ▲ +2.0%
2017 2.11x CN¥278.26 Million CN¥585.78 Million ▲ +191.0%
2016 0.72x CN¥407.05 Million CN¥294.50 Million ▲ +108.8%
2015 0.35x CN¥385.56 Million CN¥133.60 Million ▼ -43.3%
2014 0.61x CN¥277.55 Million CN¥169.73 Million ▲ +408.2%
2013 0.12x CN¥190.34 Million CN¥22.90 Million ▼ -54.0%
2012 0.26x CN¥149.29 Million CN¥39.05 Million ▼ -82.1%
2011 1.46x CN¥34.80 Million CN¥50.81 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow